{"nct_id":"NCT01660906","title":"Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib","status":"COMPLETED","status_verified_date":"2016-11","start_date":"2012-12","start_date_type":null,"primary_completion_date":"2015-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-10","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["BMY"]}